We offer complete cell bank and ***bulk*** harvest characterization for biosimilars, including cell banks, raw materials of animal origin, unprocessed/processed bulk harvests, and batches of clinical product
What does "bulk" mean in this context? Thanks in advance!
Please supply some context. Who is "we". What 'characterizations' are being spoken of? Who or what is 'biosimilar' to whom or what? What is the clinical setting for the 'clinical products' and what are they.
One sentence from some biomedical promotions bumpf is hard to understand on its own.